Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


16.09.2019

6 Acta Haematol
1 Am J Hematol
3 Blood
1 Cancer Res
1 Eur J Haematol
1 Genes Chromosomes Cancer
2 Int J Hematol
1 J Pediatr Hematol Oncol
2 Leuk Lymphoma
2 Leuk Res
1 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Haematol

  1. PAN P, Wang L, Wang Y, Shen L, et al
    Systematic Review and Meta-Analysis of -New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia.
    Acta Haematol. 2019 Sep 12:1-13. doi: 10.1159/000501537.
    PubMed     Text format     Abstract available

  2. SHARGIAN-ALON L, Raanani P, Rozovski U, Siegal T, et al
    Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
    Acta Haematol. 2019;141:19-22.
    PubMed     Text format     Abstract available

  3. RUIZ-ARGUELLES GJ
    Factors Involved in the Selection of Treatment in Patients with Hematological Malignancies.
    Acta Haematol. 2019;141:54.
    PubMed     Text format    

  4. SCHNEIDEWIND L, Neumann T, Zimmermann K, Weigel M, et al
    Is BK Virus-Associated Cystitis a Generalized Epithelial Disease?
    Acta Haematol. 2019;141:65-67.
    PubMed     Text format     Abstract available

  5. EL CHAER F, Holtzman NG, Sausville EA, Law JY, et al
    Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
    Acta Haematol. 2019;141:107-110.
    PubMed     Text format     Abstract available

  6. BIELORAI B, Leitner M, Goldstein G, Mehrian-Shai R, et al
    Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Acta Haematol. 2019;141:119-127.
    PubMed     Text format     Abstract available


    Am J Hematol

  7. MUNIR T, Brown JR, O'Brien S, Barrientos JC, et al
    Final analysis from RESONATE: up to 6 years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Am J Hematol. 2019 Sep 11. doi: 10.1002/ajh.25638.
    PubMed     Text format     Abstract available


    Blood

  8. JULIUSSON G, Hagberg O, Lazarevic VL, Olander E, et al
    Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period.
    Blood. 2019 Sep 12. pii: blood.2019001728. doi: 10.1182/blood.2019001728.
    PubMed     Text format    

  9. PARK CS, Lewis AH, Chen TJ, Bridges CS, et al
    KLF4 Represses DYRK2 Inhibition of Self-renewal and Survival Through c-Myc and p53 in Leukemia Stem/Progenitor Cells.
    Blood. 2019 Sep 12. pii: blood.2018875922. doi: 10.1182/blood.2018875922.
    PubMed     Text format     Abstract available

  10. HIJIYA N, Maschan A, Rizzari C, Shimada H, et al
    Phase 2 Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia.
    Blood. 2019 Sep 11. pii: blood.2019000069. doi: 10.1182/blood.2019000069.
    PubMed     Text format     Abstract available


    Cancer Res

  11. LY M, Rentas S, Vujovic A, Wong N, et al
    Diminished AHR signaling drives human acute myeloid leukemia stem cell maintenance.
    Cancer Res. 2019 Sep 13. pii: 0008-5472.CAN-19-0274.
    PubMed     Text format     Abstract available


    Eur J Haematol

  12. KONUMA T, Kohara C, Watanabe E, Mizukami M, et al
    Circulating unconventional T cell subsets during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia.
    Eur J Haematol. 2019 Sep 11. doi: 10.1111/ejh.13328.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  13. PINCEZ T, Landry JR, Roussy M, Jouan L, et al
    Cryptic recurrent ACIN1-NUTM1 fusions in non KMT2A-rearranged infant acute lymphoblastic leukemia.
    Genes Chromosomes Cancer. 2019 Sep 12. doi: 10.1002/gcc.22808.
    PubMed     Text format     Abstract available


    Int J Hematol

  14. FUJIOKA M, Itonaga H, Kato T, Nannya Y, et al
    Persistent clonal cytogenetic abnormality with del(20q) from an initial diagnosis of acute promyelocytic leukemia.
    Int J Hematol. 2019 Sep 12. pii: 10.1007/s12185-019-02731.
    PubMed     Text format     Abstract available

  15. WRIGHT N, Voshtina E, George G, Singavi A, et al
    Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).
    Int J Hematol. 2019 Sep 7. pii: 10.1007/s12185-019-02729.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  16. BELSKY JA, Audino AN, Kahwash SB
    Separating Lymphoblastic Lymphoma Involving Marrow From Lymphoblastic Leukemia: It is Time to Update the CutOff Number.
    J Pediatr Hematol Oncol. 2019 Sep 12. doi: 10.1097/MPH.0000000000001588.
    PubMed     Text format    


    Leuk Lymphoma

  17. YANG Q, Qian H, Jin Z, Yu Z, et al
    SET-CAN fusion gene as poor prognosis predictor in adult T-cell acute lymphoblastic leukemia.
    Leuk Lymphoma. 2019 Sep 10:1-4. doi: 10.1080/10428194.2019.1660966.
    PubMed     Text format    

  18. OKABE S, Tanaka Y, Moriyama M, Gotoh A, et al
    Efficacy of dasatinib against ponatinib-resistant chronic myeloid leukemia cells.
    Leuk Lymphoma. 2019 Sep 10:1-3. doi: 10.1080/10428194.2019.1660971.
    PubMed     Text format    


    Leuk Res

  19. BESTACH Y, Toloza MJ, Ferri C, Larripa I, et al
    The dynamic of TNF and IL6 gene expression in chronic myeloid leukemia patients reveals early responders to imatinib.
    Leuk Res. 2019;86:106221.
    PubMed     Text format    

  20. YANG L, Kost SEF, Beiggi S, Zhang Y, et al
    Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia.
    Leuk Res. 2019;86:106220.
    PubMed     Text format    


    N Engl J Med

  21. XU L, Wang J, Liu Y, Xie L, et al
    CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
    N Engl J Med. 2019 Sep 11. doi: 10.1056/NEJMoa1817426.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: